Madina Dixon
Family · Madison, MSNPI 1912268350
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $744, 2.6 times the $286 reported in 2021.
Across 98 payments — averaging $22.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$365
- Smith+Nephew$353
- Sumitomo Pharma America, Inc.$307
- Mayne Pharma Commercial LLC$236
- Axonics, Inc.$158
- Axsome Therapeutics, Inc.$124
- plus $649 from 16 others
What the payments were for
- Food & beverage$2,192100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 8 | $365 |
| Smith+Nephew | 30 | $353 |
| Sumitomo Pharma America, Inc. | 11 | $307 |
| Mayne Pharma Commercial LLC | 14 | $236 |
| Axonics, Inc. | 2 | $158 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Currax Pharmaceuticals LLC | 7 | $111 |
| AbbVie | 4 | $95 |
| Endomagnetics Ltd | 1 | $57 |
| Acella Pharmaceuticals, LLC | 3 | $57 |
| Stryker | 1 | $49 |
| Novo Nordisk | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Myriad Genetic Laboratories, Inc. | 2 | $35 |
| Bard Peripheral Vascular, Inc. | 2 | $31 |
| Abbott | 1 | $24 |
| Medline Industries LP | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Astellas Pharma Global Development | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,192 in reported general payments places this provider in the 80th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 48 | $967 |
| Estradiol | 18 | $864 |
| Levothyroxine Sodium | 19 | $87 |
Paid to pharmacies, not to this prescriber.
Other family in Madison
- Jill EasleyMadison$15K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.